Drug companies on toes amid glare on USFDA

India Business News: MUMBAI: A US congressional panel has voiced concern on the ineffective action on quality lapses taken by its national drug regulator Food and Drug Adm.

Related Keywords

China ,Mumbai ,Maharashtra ,India ,Chinese ,Robert Califf ,Us Congres Energy ,Drug Administration ,Commerce Committee ,Business News ,Usfda ,Medicine ,Drugs ,Congressional Panel ,